miR-181-5p/KLHL5 Promoted Proliferation and Migration of Gastric Cancer Through Activating METTL3-Mediated m6A Process

Morgan, E., Arnold, M., Camargo, M. C., et al. (2022). The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study. EClinicalMedicine, 47, 101404.

Chen, W., Zheng, R., Baade, P. D., et al. (2016). Cancer statistics in China, 2015. CA: A Cancer Journal for Clinicians., 66(2), 115–132.

Thrumurthy, S. G., Chaudry, M. A., Chau, I., & Allum, W. (2015). Does surgery have a role in managing incurable gastric cancer? Nature reviews Clinical oncology, 12(11), 676–682.

Schleifer, R. J., Li, S., Nechtman, W., et al. (2018). KLHL5 knockdown increases cellular sensitivity to anticancer drugs. Oncotarget, 9(100), 37429–37438.

Dhanoa, B. S., Cogliati, T., Satish, A. G., Bruford, E. A., & Friedman, J. S. (2013). Update on the Kelch-like (KLHL) gene family. Human genomics, 7, 13.

Chen, J., Ou, Y., Yang, Y., et al. (2018). KLHL22 Promotes MTORC1 activation and breast tumorigenesis. Cancer Discovery, 8(7), OF13.

Chen, J., Song, W., Du, Y., et al. (2018). Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation. Biochemical and Biophysical Research Communications, 499(3), 433–440.

Kim, M. S., Lee, H. S., Kim, Y. J., Lee, D. Y., Kang, S. G., & Jin, W. (2019). MEST induces Twist-1-mediated EMT through STAT3 activation in breast cancers. Cell Death and Differentiation, 26, 2594.

Cheaito, K. A., Bahmad, H. F., Hadadeh, O., et al. (2019). EMT Markers in locally-advanced prostate cancer: Predicting recurrence? Frontiers in oncology, 9, 131.

Di, L., Liu, L. J., Yan, Y. M., et al. (2019). Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFbeta/BMP signaling in triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research : CR, 38(1), 134.

Li, A., Zhu, X., Wang, C., et al. (2019). Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer. Scientific Reports, 9(1), 5166.

Wang, S., Ran, L., Zhang, W., et al. (2019). FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer. Scientific Reports, 9(1), 5281.

Xia, Y., Wang, L., Xu, Z., et al. (2019). Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT. Cell Proliferation. https://doi.org/10.1111/cpr.12606

Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. The Journal of Clinical Investigation, 119(6), 1420–1428.

Zhang, L., Huang, G., Li, X., et al. (2013). Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1alpha in hepatocellular carcinoma. BMC Cancer, 13, 108.

Rong, D., Wu, F., Lu, C., et al. (2021). m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression. Molecular Theraphy- Nucleic Acids., 26, 637–648.

Jiang, X., Liu, B., Nie, Z., et al. (2021). The role of m6A modification in the biological functions and diseases. Signal Transduction and Targeted Therapy, 6(1), 74.

Jin, S. F., Li, M. Y., Chang, H. Y., et al. (2019). The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma. Molecular Cancer, 21(1), 97.

Yoshida, K. (2005). Identification and characterization of a novel kelch-like gene KLHL15 in silico. Oncology Reports, 13(6), 1133–1137.

Yoshida, S., Araki, Y., Mori, T., et al. (2018). Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo. Clinical and Experimental Nephrology, 22(6), 1251–1257.

Bertocci, B., Lecoeuche, D., Sterlin, D., et al. (2017). Klhl6 deficiency impairs transitional B cell survival and differentiation. Journal of Immunology, 199(7), 2408–2420.

Zhao, S., Geybels, M. S., Leonardson, A., et al. (2017). Epigenome-wide tumor DNA methylation profiling identifies novel prognostic biomarkers of metastatic-lethal progression in men diagnosed with clinically localized prostate cancer. Clinical Cancer Research : An official journal of the American Association for Cancer Research, 23(1), 311–319.

Moghe, S., Jiang, F., Miura, Y., et al. (2012). The CUL3-KLHL18 ligase regulates mitotic entry and ubiquitylates Aurora-A. Biology Open, 1(2), 82–91.

Abou-Elhamd, A., Alrefaei, A. F., Mok, G. F., et al. (2015). Klhl31 attenuates beta-catenin dependent Wnt signaling and regulates embryo myogenesis. Developmental Biology, 402(1), 61–71.

Nguyen, H. H., Shaheen, A. A., Baeza, N., et al. (2018). Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS). PLoS ONE, 13(3), e0193960.

Hooper, S. D., Johansson, A. C., Tellgren-Roth, C., et al. (2012). Genome-wide sequencing for the identification of rearrangements associated with Tourette syndrome and obsessive-compulsive disorder. BMC Medical Genetics, 13, 123.